CellDrive has created a novel technology within the field of biotinks that offers the possibility of producing structures, tissues or organs through an additive manufacturing process, layer by layer.
CellDrive has raised €169k across 1 funding round from 1 investor, most recently a round in Jul 2021. Based in Spain; active in Deeptech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-07-01 | Other | €169k |
| BeAble Capital |
| View deal → |
